(HIMS) Hims Hers Health - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4330001060
HIMS: Telehealth, Wellness Products, Skincare, Sexual Health, Haircare
Hims & Hers Health, Inc. operates a telehealth platform connecting consumers to licensed healthcare professionals across the United States, the United Kingdom, and internationally. The company offers a range of curated health and wellness products, including prescription and non-prescription options, available for direct purchase via its websites and mobile app. Services include recurring prescription medication, ongoing care from healthcare providers, and over-the-counter products spanning categories such as general wellness, sexual health, skincare, and hair care. Its non-prescription offerings include melatonin and biotin for wellness; moisturizers, serums, and sunscreens for skincare; condoms, lubricants, and vibrators for sexual health; and shampoos, conditioners, and minoxidil-based treatments for hair care. The company also provides medical consultation and post-consultation support, along with wholesale distribution of its health and wellness products.
Based in San Francisco, California, Hims & Hers Health, Inc. has established itself as a key player in the telehealth and direct-to-consumer health products market. Its platform integrates virtual consultations with licensed professionals, enabling consumers to access personalized healthcare solutions. The companys product portfolio is designed to address a broad spectrum of health and wellness needs, with a focus on convenience, affordability, and accessibility. By leveraging technology to streamline healthcare delivery, Hims & Hers Health, Inc. aims to improve consumer access to essential health and wellness services and products.
3-Month Forecast: Based onAdditional Sources for HIMS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HIMS Stock Overview
Market Cap in USD | 6,370m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2019-09-13 |
HIMS Stock Ratings
Growth Rating | 56.1 |
Fundamental | 81.3 |
Dividend Rating | 0.0 |
Rel. Strength | 160 |
Analysts | 3.43/5 |
Fair Price Momentum | 29.73 USD |
Fair Price DCF | 5.70 USD |
HIMS Dividends
No Dividends PaidHIMS Growth Ratios
Growth Correlation 3m | -83.3% |
Growth Correlation 12m | 78.9% |
Growth Correlation 5y | 31.8% |
CAGR 5y | 27.15% |
CAGR/Max DD 5y | 0.31 |
Sharpe Ratio 12m | 1.58 |
Alpha | 136.38 |
Beta | 3.072 |
Volatility | 133.48% |
Current Volume | 36974k |
Average Volume 20d | 21315.8k |
As of May 01, 2025, the stock is trading at USD 33.10 with a total of 36,974,038 shares traded.
Over the past week, the price has changed by +23.92%, over one month by +12.01%, over three months by -11.21% and over the past year by +164.17%.
Yes, based on ValueRay Fundamental Analyses, Hims Hers Health (NYSE:HIMS) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 81.32 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HIMS as of May 2025 is 29.73. This means that HIMS is currently overvalued and has a potential downside of -10.18%.
Hims Hers Health has received a consensus analysts rating of 3.43. Therefor, it is recommend to hold HIMS.
- Strong Buy: 4
- Buy: 1
- Hold: 7
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, HIMS Hims Hers Health will be worth about 35.7 in May 2026. The stock is currently trading at 33.10. This means that the stock has a potential upside of +7.79%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 44.7 | 35% |
Analysts Target Price | 44.7 | 35% |
ValueRay Target Price | 35.7 | 7.8% |